DETOXIFICATION OF INGESTED organic toxins in the liver is dependent in part on a set of enzymes, called xenobiotic metabolizing enzymes (XME), which are controlled by a complex and overlapping set of hormonal signals and epigenetic switches (19, 25, 29, 35) . Transcriptional control of these enzymes depends on a network of interactions, including nuclear receptors that respond directly to foreign compounds. These nuclear receptors are thought to be modulated by gonadal and pituitary endocrine factors, since castration and endocrine replenishment of pituitary hormones, particularly growth hormone (GH), have a major influence on XME expression (12) (13) (14) .
Sex-specific differences in GH pulse pattern play an important role in determination of expression of XME genes in rodent liver (19, 35) . The male pattern is characterized by peaks of GH secretion, with a periodicity of ϳ3 h, followed by trough periods with much lower GH production. In contrast, female GH production is relatively constant, with lower peak levels and without the very low trough levels seen in males. These sex-specific differences result from changes in hypothalamic function acquired early in postnatal life (15) but are subject to modification in adult life by manipulation of gonadal hormones (29) . Maintenance of the male GH pulse pattern depends upon the central circadian pacemaker in the suprachiasmatic nucleus; deletion of the cryptochrome genes that mediate circadian rhythmicity can convert the male pattern of hepatic XME expression to a pattern closer to that seen in females (5) .
In mice, XME genes expressed at high levels in males can be divided into subclasses based on the effects of pituitary ablation in females (35) . Some of these mRNAs are actively repressed in females by the male-specific GH pulse pattern, whereas others require at least some GH for transcription. Similarly, genes highly expressed in young adult females include a subset in which male GH pulses lead to repression of transcription, and another subset in which GH is required for transcription even in females. Transcription of XME genes is modulated by a set of factors, including STAT5b (6) and HNF4a (17) . Regulation of XME genes is thought to depend upon the pregnane X receptor (PXR) and constitutive androstane receptor (CAR) (34) . In contrast, a study in which GH-releasing hormone (GHRH) receptor mutant mice, deficient in GH production, were crossed onto backgrounds with deficits in specific nuclear receptors (1) suggested that GHdependent repression of female-specific XME genes depended on the farnesoid X receptor rather than on PXR or CAR in this setting.
Experiments in mice (1, 2) and in nematode worms (3, 22, 26, 30) have suggested that the long lifespan seen in mutants that interfere with GH production or GH mediators such as IGF-I might be mediated, in part, by augmented function of XME genes. Upregulation of XME genes is postulated to protect long-lived mutants from exogenous toxins and perhaps endogenous metabolic byproducts that could contribute to late-life pathology. A previous study from this laboratory (31) showed elevation of multiple XME mRNAs in liver of mice bearing lifespan-extending mutations, including a global knockout of the GH receptor ("GHR-KO" or GKO mice) and the pituitary mutant Snell dwarf (Pit1 dw/dw ). Genes elevated in these two mutants, deficient in production of or response to GH, were also elevated in mice exposed to lifelong caloric restriction or to transient milk restriction during the weaning period only, both of which also increase lifespan (10, 32) . This previous report, however, included data only from male animals, and most of the mRNAs evaluated were from a set known to be overexpressed in females. In the current study, we have now conducted a broader analysis that includes female mice and includes mRNAs typically expressed at higher levels in males to test the hypothesis that elevated expression of XME genes is associated with lifespan extension in both sexes. In addition, we evaluated XME expression in the liver of mice in which GHR is ablated specifically in liver, in muscle, or in fat alone to determine to what extent GH control of hepatic XME transcription is mediated directly by GH effect in the liver, or indirectly via GH effects in other tissues.
METHODS
Cre-lox-mediated GHR tissue-specific gene-disrupted mouse line production. A mouse line carrying the conditional GHR floxed allele was generated as previously described (20) , in a pure C57BL/6N background stock. The three tissue-specific GHR Ϫ/Ϫ mouse lines were then generated by breeding the GHR flox/flox mice to one of three Cre-recombinase transgenic mouse lines, each acquired from the Jackson Laboratory (Bar Harbor, ME). The adipose tissue-specific GHR Ϫ/Ϫ mouse line ("FKO") was generated by breeding GHR flox/flox mice to B6.Cg-Tg(Fabp4-cre)1Rev/J mice. Liver tissue-specific GHR Ϫ/Ϫ mice ("LKO") were generated by breeding GHR flox/flox mice to B6.Cg-Tg(Alb-cre)21Mgn/J mice. Skeletal muscle-specific GHR Ϫ/Ϫ mice ("MKO") were generated by breeding the conditional GHR flox/flox mice to B6.FVB(129S4)-Tg(Ckmm-cre)5Khn/J mice. All three Cre-recombinase transgenic mouse lines were previously backcrossed into the C57BL/6J strain; therefore, the resulting cre-lox tissue-specific mouse lines were a mix of C57BL/6J and C57BL/6N substains. Breedings were coordinated in such a manner that all three tissue-specific mouse lines used were C57BL/6 with an ϳ62.5% "J" and 37.5% "N" substrain mixture at Ohio University. Breeding pairs for each line were shipped from Ohio University to the University of Michigan where they were maintained in the same C57BL/6 (62.5% J/37.5% N) substrain mixture for all studies described herein. The experimental protocols were reviewed and approved by the University Committee on the Use and Care of Animals at the University of Michigan.
UM-HET3 mice. These mice are produced by a cross between CB6F1 mothers and C3D2F1 fathers, as described (24) ; each mouse is genetically unique and shares 50% of its polymorphic alleles with each other mouse in the population.
GKO stock. Mice heterozygous for a null mutation at GHR (7) on the C57BL/6J background were obtained from Ohio University and bred at the University of Michigan to BALB/cJ females to produce CB6F1 offspring. GH receptor (GHR) heterozygous animals of this F 1 generation were then crossed to produce CB6F2 mice, among which homozygotes for the GHR mutation were used as GKO, with nonmutant mice (a mixture of GHR heterozygotes and wild-type homozygotes) used as littermate controls.
RNA isolation and RT-PCR analysis. Liver tissue was obtained from adult mice 8 -11 mo of age. Total RNA was isolated from mouse livers using Trizol (Invitrogen, Carlsbad, CA) according to the manufacturer's instruction. The RNA was cleaned using the QiagenRNeasy mini RNA cleanup protocol (Qiagen, Valencia, CA). The concentration of total RNA in each sample was quantified using a Nanodrop ND-100. Total RNA was transcribed to single-stranded cDNA by using iScript cDNA reverse transcription kits (1708891; BIO-RAD, Hercules, CA). Reverse transcription products were then amplified with PCR, by using Power SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA) and PCR primers (Integrated DNA Technologies, Coralville, IA). RT-PCR was performed using ABI PRISM sequence detection system instrument and software (Applied Biosystems). Primer sequences for each of the 52 XME mRNAs evaluated are compiled in Supplemental  Table S1 (Supplemental data for this article may be found on the American Journal of Physiology: Endocrinology and Metabolism website.). Some of these mRNAs were evaluated in an independent sample of GKO mice in an independent cohort of mice described earlier (31); we found an excellent correlation, at R ϭ 0.92, between these two independent sets of determinations.
Data reduction and statistical analysis. C t data, indicating the number of amplification cycles needed to achieve threshold, were available from six mice for each combination of mRNA, sex, and genotype. The effect of each mutation was estimated as the difference between C t for the mutant mouse and Ct for sex-matched littermate controls, with a positive value in cases where expression of the mRNA was increased in the knockout stock compared with nonmutant control littermates of the same stock. Because a change of 1 unit for C t reflects a twofold change in mRNA abundance, effect sizes in Figs. 1-4 
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Consistent patterns of sexual dimorphism.
Sexual dimorphism of XME mRNAs in the mouse has been described mainly in C57BL/6 mice, which may not be representative of other genotypes or of noninbred mice more generally. To evaluate strain-to-strain variation in sexual dimorphism, we measured mRNA for 52 XME genes in six nonmutant males and six nonmutant females of the LKO (nearly inbred), GKO (F 2 hybrid), and UM-HET3 (4-way cross) stocks. As shown in Fig. 1 , left, there was good agreement in the female-to-male (F/M) ratio for each variety of these control mice, with R 2 values ranging from 0.62 to 0.83. F/M ratios ranged from about 2 Ϫ10 for the male-predominant genes to about 2 14 for femalepredominant genes. As shown in Fig. 1 , right, control mice generated as littermates of the LKO, FKO, and MKO mice also were similar in their pattern of sexual dimorphism, with interpopulation R 2 values ranging from 0.35 to 0.71. LKO, GKO, and MKO control mice share a nearly inbred background derived from C57BL/6N and C57BL/6J progenitors. These results are consistent with previous evidence (27) that interanimal variation is typically higher within an inbred stock than in hybrid stocks. For evaluation of the extent to which effects of LKO, MKO, and FKO mutations might be related to sexual dimorphism, we used the mean level of F/M ratio, averaged across the LKO, MKO, and FKO control animals, and used this average F/M ratio to determine gene order in Figs. 1-4, and in the corresponding Supplemental Tables S1 and S2 .
Effects of a global GHRKO mutation correlate strongly with F/M ratio in males but not in females. The top two panels of Fig. 2 show the effects of the GKO mutation on mRNA levels of all 52 evaluated XME genes in males and females. Genes expressed at higher levels in female controls are shown at the left of each panel, and genes expressed at high levels in males are shown at the right of each panel, with the Log2 F/M ratio varying over a range of Ͼ500,000-fold (2 12 -2 Ϫ7 ), presented in the bottom panel for reference. Of the 20 genes with highest female predominance in controls, 17 increase in the GKO males (12 of them with P Ͻ 0.01), and, of the 12 genes with highest male predominance, all 12 decline in male GKO mice, 7 of these with P Ͻ 0.01. Thus the pattern of XME mRNA in GKO males resembles the pattern expected for female control mice. Gene names, with quantitative values for each gene in each sex, are shown in Supplemental Table S2 , which presents the genes in the same order used for Figs. 2 and 3.
In contrast, the effects of the GKO mutation in females (second panel in Fig. 2 ) are less dramatic and show little association with the wild-type F/M ratio. Of the 20 genes with highest F/M ratios, for example, three show significant declines and three show significant increases (at P Ͻ 0.01). Of the 12 genes with strongest male predominance, none shows a significant decline, and only one shows a significant increase at P Ͻ 0.01. There is no general association, across the set of mRNAs, between GKO effect in males and GKO effect in females (R ϭ 0.16, P ϭ 0.3). Only six genes show significant increases in both males and females: Cyp2b10, Cyp2b13, Sult1e1, Sult1d1, Cyp2a4, and Cyp2a5 (genes 6, 15, 20, 24, 25 , and 32 in Figs. 1-4 and in Supplemental Table S1 ).
Effects of the liver-specific LKO mutation also correlate strongly with F/M ratio only in males. Panels 3 and 4 of Fig.  2 show the effects of the LKO mutation on mRNA levels of the 52 evaluated XME genes. Of the 20 genes with highest female predominance in controls, 15 increase in the LKO males (10 of them with P Ͻ 0.01), and, of the 15 genes with highest male predominance, all 15 show a significant (P Ͻ 0.01) decline in male LKO mice. Thus the pattern of XME mRNA in LKO males, like that seen in male GKO mice, resembles the pattern expected for female controls. The effects of the LKO mutation in females (panel 4 of Fig. 2) show less consistency. Of the 20 genes with highest F/M ratios, for example, five show significant declines and two show significant increases (at P Ͻ 0.01), and, of the 15 genes with strongest male predominance, there are two significant increases and one significant decline. There is no association, across the mRNAs, between LKO effect in males and LKO effect in females (R ϭ Ϫ0.18, P ϭ 0.2). Only one mRNA, Cyp2b13 (gene 15 in Figs. 1-4 and Supplemental Table S2 ), shows a significant increase in both males and females of the LKO stock (an increase of 2 6 in males and 2 10 in females), and only one mRNA, Cyp7b1 (gene 47), shows a significant decline in both sexes (2 Ϫ3 , an 8-fold decline, in each sex).
Because many of the effects of GH on liver are expected to reflect direct action of the hormone on hepatocytes, we expected that effects of the GKO mutation would be largely recapitulated in the LKO mice. This expectation was only partially supported by the data. There is a correlation, across the mRNA, between LKO effect and GKO effect in both sexes (see scatterplots in Fig. 4, below) , but the correlation is only modest, and it is higher in males (R ϭ 0.63, P Ͻ 0.0001) than in females (R ϭ 0.42, P Ͻ 0.002).
Indirect effects on liver XME expression by GH gene disruption in adipose tissue. Differences in gene expression patterns between GKO and LKO mice are consistent with the idea that some of the effects seen in GKO mice might result from indirect influences, for example, alteration in liver physiology secondary to GH effects in fat or muscle. Data on liver gene expression in FKO and MKO mice are shown in Fig. 3 . Of the 52 mRNA evaluated, 8 show significant (P Ͻ 0.01) elevation, and 2 show significant decline, in male FKO mice. Similarly, there are six significant elevations and six significant declines in liver mRNA in the FKO females. Seven other mRNAs show evidence for some change in males (using P Ͻ 0.05 as criteria), in addition to one such mRNA in females. These results show that deletion of GH from fat has a substantial influence on liver patterns of XME mRNA expression. The majority of the changes seen are in genes with a male predominance in control mice, but there are also significant alterations in femalepredominant genes and in genes with a F/M ratio close to one. Of the 52 mRNAs, 90% (47/52) increase to some extent in the male FKO mice (although not always to a statistically significant degree); in females, 75% of the mRNA (39/52) show some increase. These proportions are much higher than would be expected by chance (P Ͻ 0.0001 for males, P ϭ 0.0003 for females), showing that the effects of the FKO mutations on liver XME gene expression are nonrandom in direction. There is no clear relationship between genes that change in male FKO and those that change in female FKO: Pearson correlation gives R ϭ Ϫ0.25, P ϭ 0.07, a trend toward negative correlation, but the rank-based Spearman correlation shows no evidence for similar changes in each sex (R ϭ 0.1, P ϭ 0.5).
Indirect effects on liver XME expression by GH gene disruption in muscle tissue. Figure 3 also shows XME mRNA changes in MKO mice in which GHR is ablated specifically in skeletal muscle. Changes in liver XME gene expression are much smaller in MKO mice than in FKO mice, with few individual mRNAs showing a significant change. It is noteworthy, however, that 37 of the 52 mRNA species are elevated in the MKO males, as opposed to 13/52 mRNA in female MKO mice. Both ratios are significantly different from the 1:1 ratio of increases to decreases that would be produced by random chance alone: P ϭ 0.003 for males (2-tailed) and P ϭ 0.0004 for females.
Effects of GKO, LKO, FKO, and MKO are correlated across XME genes in liver. Figure 4 displays scatterplots for mean level of mRNA (averaged over six mutant mice of each type), with males shown in the bottom left triangle and females in the top right part of the figure. Several of the relationships are worth special attention. As expected from the assumption that liver gene expression reflects, at least in part, direct effects of GH signals on hepatocytes, there is a significant correlation between GKO and LKO gene expression patterns in both sexes. The extent of correlation is, however, higher in males, Fig. 2 . Effects of LKO and GKO of GHR on XME mRNA levels in liver tissue of male and female mice. Each of the four panels on top shows a separate group of mice: GKO males, GKO females, LKO males, and LKO females. Each bar represents one of 52 XME genes, presented in the same order in each panel. The values, shown on a Log2 scale, represent the average mRNA in N ϭ 6 KO mice divided by the average mRNA in N ϭ 6 littermate control mice of the same stock. Bars shown in red are those for which P(t) Ͻ 0.01 (unadjusted for multiple comparisons); those in orange are mRNA for which 0.01 Ͻ P(t) Ͻ 0.05, and those in grey are for P(t) Ͼ 0.05. Vertical lines in each panel are placed at intervals of 10 mRNAs for orientation. The panel at the bottom shows the F/M ratio for the genes as an average of the F/M ratio in nonmutant controls of the LKO, fat knockout (FKO), and skeletal muscle knockout (MKO) stocks. Note that the vertical scales for GKO mice range from 2 10 to 2 Ϫ10 , but those for the LKO range from 2 15 to 2 Ϫ15 .
consistent with previous data showing that many XME genes are controlled by male-specific patterns of GH pulsatility (9, 21), which would have less effect on hepatocytes in both LKO and GKO males. There is, unexpectedly, a negative association between effects seen in male LKO mice and those seen in male FKO and MKO mice: those mRNA that are decreased in male LKO animals, most of which are male predominant in wildtype controls (see Fig. 2 ), tend to show increased expression in both FKO (P Ͻ 0.0001) and MKO (P ϭ 0.003) males. Similarly, there is a negative correlation between an effect in GKO males and an effect in FKO or MKO males, although here the correlation coefficient is smaller than for the LKO males. None of these correlations are seen in comparisons of female FKO or MKO mice with LKO or GKO females.
DISCUSSION
Hepatic expression of mRNA for XME genes differs greatly between males and females, with sexual dimorphism documented in mice, rats, and humans (8, 16, 25, 28, 35) . Among the hundreds of genes that have been evaluated, the majority show higher levels of expression in females than in males. Experiments involving hypophysectomy, replenishment of pituitary hormones, and modulation of gonadal hormones by surgical, genetic, or pharmacological means have produced a model in which the male pattern of GH secretion, characterized by relatively large differences between peak and trough levels, actively suppresses expression of many XME mRNAs. The relatively unvarying levels of GH in female adults, with lower peak levels and less prolonged trough periods, fails to suppress genes in this category, leading in such cases to a dramatically elevated XME mRNA level in females. A subset of hepatic XME mRNAs, however, are highly expressed in males. Among these, some have been shown to be stimulated by GH and others to be upregulated in males through mechanisms that do not involve GH levels. Among genes expressed at higher levels in female mice, some ("Class II" in Waxman's terminology; see Ref. 35 ) increase in males when the pituitary is removed, suggesting that their level is suppressed by GH in male mice. A second group of female-predominant mRNAs are not altered by hypophysectomy in males but instead decline in hypophysectomized females, suggesting that the female GH pattern may be needed to stimulate transcription for this group. Waxman and his colleagues have been able to attribute these patterns of gene expression to sex-specific and hormone-dependent changes in pathways controlled by STAT5b and HNF4a (17) . Curiously, male-specific expression of XME genes in kidney seems to be related to testosterone levels directly, rather than to male-specific patterns of GH production (33) .
Mice with mutations that reduce GH production, such as the Ames dwarf (Prop1 df/df ) mice studied by Amador-Noguez et al. (2) , provided one approach to testing the role of GH in sex-specific modulation of hepatic mRNAs. An array-based analysis documented 110 gender-specific alterations in liver mRNA expression, nearly all of which reflected a loss of sexual dimorphism in the Ames dwarf animals. The loss of sexual dimorphism included genes involved in xenobiotic metabolism as well as metabolism of sex hormones and fatty acids. Many of the XME mRNAs have been reported to change with age and in a sex-specific way. XME genes whose expression, in liver, increases with age tend to be those that are female predominant in young rats, whereas those that show an age-dependent decrease are typically more highly expressed in young male rats than in young females rats (18) . These authors speculate that the age-dependent decline in male-specific GH pulse patterns could contribute to these changes so that XME gene expression in aged rats resembles that seen in young females.
The availability of new mouse strains in which GHR has been reduced specifically in liver, muscle, and fat provides tools to determine to what extent hepatic expression of XME genes is regulated directly by liver response to GH, or instead by indirect effects mediated by GH action on other tissues. The results displayed in Figs. 2 and 3 support, to some extent, models in which sex-specific patterns of XME mRNA reflect differences between young males and females in GH pulse patterns but reveal many exceptions that are not consistent with this simplified model. In general, male GKO and LKO mice do, as expected, show elevated expression of female-predominant mRNAs, and show reduced expression of male-predominant mRNAs, consistent with the idea that GH pulses are needed both for activity of male-specific mRNAs and for repression of female-specific XME genes. There are many exceptions, however, in which GKO or LKO males show significant changes in genes that are expressed at similar levels in male and female control mice. Comt (gene 30 in Figs. 1-4 and Supplemental Table S2 ) provides one such example, showing a 7,100-fold decrease in LKO males, even though expression of Comt in wild-type animals does not show appreciable sexual dimorphism (F/M ratio of 1.7). Comt is also an example of a gene whose response to GHR loss differs between global GKO mice and liver-specific LKO mice: LKO males show a 7,100-fold decline, but GKO males decline only 1.8-fold (not significant). Inspection of Fig. 2 and Supplemental Tables S2a  and S2b shows several other mRNA where the decline in LKO males greatly exceeds that of GKO males. Our LKO and GKO stocks are not matched for background, and it is possible that these discrepancies might reflect effects of unknown background alleles. Alternately, these examples may reflect alterations in the liver of LKO mice that are muted, by compensatory effects in other tissues, when GHR is ablated globally.
GKO and LKO mutations in female mice ( Fig. 2 and Supplemental Tables S2a and S2b) affect fewer XME genes, and the amount and direction of mRNA effect does not vary in a systematic way with the level of sexual dimorphism in control animals. The three mRNAs with the most extensive increase in male LKO mice (Sult3a1, Sult2a2, and Cyp2b, genes 1, 2, and 3 in Figs. 1-4 ) are all significantly decreased in LKO females, suggesting that male GH pulse pattern represses these genes in males and that GH is also required for expression in females. There are, however, large and unexpected discrepancies between LKO and GKO females: of these three mRNA decreased in the LKO mice, only the first shows a similar decline in GKO females. Similarly, many of the effects seen are not explained by the standard model: for one example, Cyp2b13 (gene 15 in Figs. 1-4) is increased by LKO in both males (91-fold) and females (780-fold).
The data from the FKO mice ( Fig. 3 and Supplemental Table  S2c ) strongly suggest that modulation of GH signals in adipose tissue can have dramatic effects in liver XME gene expression. Of the 52 mRNA evaluated, 47 showed higher levels in FKO males than wild-type littermates, including nine examples where P Ͻ 0.01 and another six where P Ͻ 0.05 for the genotype effect. The largest increases in XME gene expression were for male-predominant mRNAs, so that, for these genes, removal of GH signals in fat led, through unknown effectors, to augmented expression of hepatic genes already expressed at high levels in control males. Effects in FKO females were less consistent. Of the 11 XME genes whose expression in male controls exceeds that of females by at least twofold, six decline and five increase in FKO females.
In the MKO males, 35 of the 52 tested genes show increased expression compared with MKO control littermates, and this proportion differs from the null hypothesis (no consistent direction of change) at P ϭ 0.01. In contrast, 39 of the 52 genes show decreased expression in MKO females (P ϭ 0.0003). Thus deletion of GHR in muscle leads to alterations in liver pattern of XME gene expression, but the direction of change differs between the sexes. These effects are small, however, in both sexes. In males, none of the changes exceeds twofold, and, in females, only five of the changes reach twofold. There is no association between the change seen in MKO mice with the F/M ratio in controls, making it unlikely that sex-specific differences in GH pulse patterns are involved in the MKO effect on liver XME expression. Female MKO mice show a significant increase in serum GH levels (2.3ϫ increase, P ϭ 0.007), and males show an increase of 1.8-fold that did not reach statistical significance (List, Berryman, and Kopchick, unpublished observation). Female MKO mice also show significant increases in three of the IGF-binding proteins. Neither males nor females, however, show significant changes in serum IGF-I levels. A more detailed report of the phenotype of muscle-specific GHR knockout mice is now in preparation. It is plausible that changes in GH/IGF-I, or in other modulators of glucose and fatty acid metabolism, may contribute to the alterations seen in liver XME gene expression, but testing this idea will require a great deal of additional work.
The scatterplots shown in Fig. 4 lead to some additional insights. We expected that the effects of GKO and LKO mutations would be similar, and indeed correlations for LKO and GKO are significant in both sexes, although only moderate in size and stronger in males (R ϭ 0.63) than in females (R ϭ 0.42). For male mice, those genes whose expression is increased in LKO and GKO males are typically decreased in the FKO and MKO males. The four relevant scatterplots, all at the bottom left of Fig. 4 , all show negative correlations; three of these are significant, and the fourth has P ϭ 0.053. Thus, for males, blockage of GH signals in fat or muscle tends to produce the opposite effects of those seen in mice where GH signals are blocked in liver alone, or in the global GHR knockout. FKO and MKO females, however, do not show any such relationship when their patterns of hepatic XME expression are compared with those seen in LKO or GKO females. The mechanisms that produce these complex sex-specific effects are at this point still unexplored.
While identification of signals responsible for alteration of hepatic gene expression in FKO and MKO mice is outside the scope of this study, we suspect that the observed changes may have been due to altered levels of adipokines such as leptin, adiponectin, resistin, adipsin, or proinflammatory cytokines in FKO mice and myokines, such as irisin, adiponectin, or IL-6, in MKO animals. Circulating levels of adiponectin and resistin were, unexpectedly, not altered in FKO mice, but adipsin levels were significantly diminished (20) . In addition, GKO and FKO mice differ in the distribution of adiposity: GKO mice have increased subcutaneous fat, whereas FKO mice show increased adiposity in all adipose depots. The published report also notes small, but statistically significant, sex-specific changes in IL-6 (females only), IGF-I (significant in males only, a 22% change), and leptin (2-fold increase, significant in males only). Approximately 20 other soluble receptors and cytokines were evaluated in parallel but not reported in the paper, raising the possibility that some of the changes seen in one sex only may have represented false discoveries in a series of multiple comparisons. Teasing out the pathway(s) by which these, or more likely other, untested products of adipocytes or fat-associated macrophages modulate liver XME gene expression will take a good deal of additional work. Our new data make it seem likely that secreted factors, or changes in metabolite levels, communicate fat depot status to the liver, directly or indirectly, but we do not yet have specific molecular pathways that seem "best candidates" for such a role. Analysis of endocrine mediators in the MKO mice is now in progress.
We expected to see some overlap of findings in LKO and GKO mice, as reflected in Fig. 4 , since both mutations interfere with the direct effects of GH on the liver. Circulating levels of IGF-I are also suppressed dramatically in both GKO and LKO mice but are unlikely to contribute to changes in hepatic gene expression patterns because hepatocytes express low levels of IGF-I receptors and do not respond to alterations in systemic IGF-I levels. The differences in hepatic gene expression between GKO and LKO mice are more surprising and seem likely to represent effects of GH on nonhepatic tissues that modulate liver function. GKO mice are resistant to GH levels in all tissues, but tissues in LKO mice remain GH responsive, and indeed the loss of feedback circuits in LKO mice leads to high elevated levels of GH that could in turn affect the liver indirectly through effects on adipose tissue, hypothalamus, or other GH-sensitive organs.
Differences in GH production between male and female mice reflect sex-specific variation in the proportion of pituitary cells that produce GH in responses to Ghrh (29) , a proportion that can itself be modulated by gonadectomy and by hormonal replacement in adult life. It would be of interest to what extent differences between male and female mice with organ-specific GHR deletion could be affected, after puberty, by endocrine manipulations of this kind.
Males of the long-lived Ames dwarf stock express many liver XME genes at higher levels than male controls (1). Similar elevation of expression of genes involved in xenobiotic detoxification in long-lived mutants of Caenorhabditis elegans (22, 23, 26) has prompted speculation (11) that augmented XME function may be an important element in control of longevity in both nematodes and mammals. Our previous report (31) supported this idea by showing similar patterns of XME overexpression in many varieties of slow-aging mice, including those in which lifespan extension was caused by caloric restriction, the hypopituitary Snell dwarf mutation, transient early life milk deprivation, or global GHR-KO. These earlier studies were limited to male mice and focused particularly on XME mRNA that were female predominant. Our current data, however, now undermine this overly simplified hypothesis by including data on female GKO mice and by including data on XME genes that are male predominant. It now seems unlikely that the long lifespan of GKO mice, which is seen in both males and females (4, 7), can be attributed to elevated levels of XME gene expression. For example, most of the (female-predominant) mRNAs that are elevated in male GKO mice are not elevated in females, and XME that are male predominant are depressed in male GKO mice (see Fig. 2 ). In retrospect, much of the change previously reported in our male GKO mice, and now seen in male LKO mice as well, can be accounted for by responses to male-specific GH pulse patterns. It is possible that a more detailed evaluation of XME gene expression levels may eventually document changes that are shared, in extent and direction, by both male and female GKO mice and perhaps by other genetic or pharmacological interventions that lengthen lifespan. The majority of XME genes, and proteins, are expressed at higher levels in female mice, rats, and humans, and it is plausible that improved detoxification of xenobiotic chemicals, or toxic endogenous metabolites, might contribute to longevity advantages of females compared with males in human population and many rodent strains. Lifespan data for the LKO, MKO, and FKO mice, not yet available, will also provide additional leverage for assessment of the possible role of XME transcription in control of aging rate and longevity.
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